SEARCH

SEARCH BY CITATION

References

  • 1
    Trends in fertility and infant and maternal health – United States, 1980–88. MMWR Morbidity and Mortality Weekly Report 1991; 40:381383, 389–390.
  • 2
    Amon E. Premature labor. In: Medicine of the Fetus and Mother. Editors: Reece EA, Hobbins JC Mahoney MJ, Petrie RH. Philadelphia, PA: J. B. Lippincott, 1992; pp. 13981429.
  • 3
    Ehrenhaft PM, Wagner JL, Herdman RC. Changing prognosis for very low birthweight infants. Obstetrics and Gynecology 1989; 74:528535.
  • 4
    Carr-Hill RA & Hall MH. The repetition of spontaneous preterm labour. British Journal of Obstetrics and Gynaecology 1985; 92:921928.
  • 5
    Ekwo EE, Gosselink CA, Moawad A. Unfavorable outcome in penultimate pregnancy and premature rupture of membranes in successive pregnancy. Obstetrics and Gynecology 1992; 80:166172.
  • 6
    Bakketeig LS & Hoffman HJ. Epidemiology of preterm birth: results from a longitudinal study of births in Norway. In: Preterm Labor. Editors: Elder LS, Hendricks CH. London/Boston: Butterworth, 1981; pp. 1746.
  • 7
    Kliegman RM, Rottman CJ, Behrman RE. Strategies for the prevention of low birthweight. American Journal of Obstetrics and Gynecology 1990; 162:10731083.
  • 8
    Harper PS. Myotonic Dystrophy. 2nd edn. Philadelphia: W.B. Saunders, 1989.
  • 9
    Cunningham FG, MacDonald PC, Gant NF, Leveno KJ, Gilstrap LC, Hawkins GDV, et al. (eds.). Parturition. In: Williams Obstetrics 20th edn. Stamford, CT: Appleton & Lange, 1997; pp. 261317.
  • 10
    Goldenberg RL, Cliver SP, Mulvihill FX, Hickey CA, Hoffman HJ, Klerman LV, et al.Medical, psychosocial and behavorial risk factors do not explain the increased risk for low birth weight among black women. American Journal of Obstetrics and Gynecology 1996; 175:13171324.
  • 11
    Porter TF, Fraser AM, Hunter CY, Ward RH, Varner MW. The risk of preterm birth across generations. Obstetrics and Gynecology 1997; 90:6367.
  • 12
    Blackwelder WC & Elston RC. A comparison of sib-pair linkage tests for disease susceptibility loci. Genetic Epidemiology 1985; 2:8597.
  • 13
    Suarez BK & Van Eerdewegh P. A comparison of three affected-sib-pair scoring methods to detect HLA-linked disease susceptibility genes. American Journal of Medical Genetics 1984; 18:135146.
  • 14
    Rothstein JL, Johnson D, Delois JA, Skowronski J, Solter D, Knowles B. Gene expression during preimplantation mouse development. Genes and Development 1992; 6:11901201.
  • 15
    Kramer KK, Duffy JY, Klemann SW, Bixby JA, Low BG, Pope WF, et al.Selective cloning of cDNA for secretory proteins of early embryos. Journal of Biological Chemistry 1994; 269:72557261.
  • 16
    Lefevre F & Boulay V. A novel and atypical type one interferon gene expressed by trophoblast during early pregnancy. Journal of Biological Chemistry 1993; 268:1976019768.
  • 17
    Romero R, Avila C, Brekus CA, Morotti R. The role of systemic and intrauterine infection in preterm parturition. Annals of the New York Academy of Sciences 1991; 622:355375.
  • 18
    Bone RC, Balk RA, Cerra B, Dellinger RP, Fein AM, Knaus WA, et al.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101:16441655.
  • 19
    Romero R, Wu YK, Brody DT, Oyarzun E, Duff GW, Durum SK. Human decidua: a source of interleukin-1. Obstetrics and Gynecology 1989; 73:3134.
  • 20
    Romero R, Mazor M, Sepulveda W, Avila C, Copeland D, Williams J. Tumor necrosis factor in pre-term and term labor. American Journal of Obstetrics and Gynecology 1992; 166:15761587.
  • 21
    Casey ML, Cox SM, Beutler B, Milewich L, MacDonald PC. Cachectin/tumor necrosis factor-α formation in human decidua: potential role of cytokines in infection-induced pre-term labor. Journal of Clinical Investigation 1989; 83:430436.
  • 22
    Vince G, Shorter S, Starkey P, Humphreys J, Clover L, Wilkins T, et al.Localization of tumour necrosis factor production in cells at the materno/fetal interface in human pregnancy. Clinical and Experimental Immunology 1992; 88:174180.
  • 23
    Fortunato SJ, Menon RP, Swan KF, Menon R. Inflammatory cytokine (interleukins 1, 6, 8 and tumor necrosis factor-α) release from cultured human fetal membranes in response to endotoxic lipopolysaccharide mirrors amniotic fluid concentrations. American Journal of Obstetrics and Gynecology 1996; 174:18551862.
  • 24
    Dudley DJ, Collmer D, Mitchell MD, Trautman MS. Inflammatory cytokine mRNA in human gestational tissues: implications for term and pre-term labor. Journal of the Society for Gynecologic Investigation 1996; 3:328335.DOI: 10.1016/s1071-5576(96)00042-1
  • 25
    Baergen R, Benirschke K, Ulich TR. Cytokine expression in the placenta: the role of interleukin 1 and interleukin 1 receptor antagonist expression in chorioamnionitis and parturition. Archives of Pathology and Laboratory Medicine 1994; 118:5255.
  • 26
    Steinborn A, Gunes H, Roddiger S, Halberstadt E. Elevated placental cytokine release, a process associated with pre-term labor in the absence of intrauterine infection. Obstetrics and Gynecology 1996; 88:534539.
  • 27
    Romero R, Avila C, Santhanam U, Sehgal PB. Amniotic fluid interleukin-6 in pre-term labor: association with infection. Journal of Clinical Investigation 1990; 85:13921400.
  • 28
    Romero R, Yoon BH, Mazor M, Gomez R, Diamond MP, Kenney JS, et al.The diagnostic and prognostic value of amniotic fluid white blood cell count, glucose, interleukin-6, and Gram stain in patients with preterm labor and intact membranes. American Journal of Obstetrics and Gynecology 1993; 169:805816.
  • 29
    Romero R, Yoon BH, Mazor M, Gomez R, Gonzalez R, Diamond MP, et al.A comparative study of the diagnostic performance of amniotic fluid glucose, white blood cell count, and interleukin-6, and Gram stain in the detection of microbial invasion in patients with preterm premature rupture of membranes. American Journal of Obstetrics and Gynecology 1993; 169:839851.
  • 30
    Dudley DJ, Trautman MS, Araneo BA, Edwin SS, Mitchell MD. Decidual cell biosynthesis of interleukin-6: regulation by inflammatory cytokines. Journal of Clinical Endocrinology and Metabolism 1992; 74:884889.
  • 31
    Dudley DJ, Trautman MS, Edwin SS, Lundin-Schiller S, Mitchell MD. Biosynthesis of interleukin-6 by cultured human chorion laeve cells: regulation by cytokines. Journal of Clinical Endocrinology and Metabolism 1992; 75:10811086.
  • 32
    Heyborne KD, McGregor JA, Henry G, Witkin SS, Abrams JS. Interleukin-10 in amniotic fluid at midtrimester: immune activation and suppression in relation to fetal growth. American Journal of Obstetrics and Gynecology 1994; 171:5559.
  • 33
    Greig PC, Herbert WNP, Robinette BL, Teot LA. Amniotic fluid interleukin-10 concentrations increase through pregnancy and are elevated in patients with preterm labor associated with intrauterine infection. American Journal of Obstetrics and Gynecology 1995; 173:12231227.
  • 34
    Cadet P, Rady PL, Tyring SK, Yandell RB, Hughes TK. Interleukin-10 messenger ribonucleic acid in human placenta: implications of a role for interleukin-10 in fetal allograft protection. American Journal of Obstetrics and Gynecology 1995; 173:2529.
  • 35
    Roth I, Corry DB, Locksley RM, Abrams JS, Litton MJ, Fisher SJ. Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10. Journal of Experimental Medicine 1996; 184:539548.
  • 36
    Dudley DJ, Edwin SS, Van Wagoner J, Augustine NH, Hill HR, Mitchell MD. Regulation of decidual cell chemokine production by group B streptococci and purified bacterial cell wall components. American Journal of Obstetrics and Gynecology 1997; 177:666672.
  • 37
    Fortunato SJ, Menon R, Swan KF, Lombardi SJ. Interleukin-10 inhibition of interleukin-6 in human amniochorionic membrane: transcriptional regulation. American Journal of Obstetrics and Gynecology 1996; 175:10571065.
  • 38
    Dizon-Townson D, Major H, Ward K. A promoter mutation that increases transcription of the tumor necrosis factor-α gene is not associated with preterm delivery. American Journal of Obstetrics and Gynecology 1997; 177:810813.
  • 39
    Dizon-Townson D, Kinney S, Lu J, Ward K. A promoter mutation in the tumor necrosis factor-α a possible association with intra-amniotic infection and preterm delivery. American Journal of Obstetrics and Gynecology 1999; 180(Suppl.):S97.
  • 40
    Roberts AK, Monzon-Bordonaba F, Van Deerlin PG, Holder J, Macones GA, Morgan MA, et al.Association of the polymorphism within the promoter of the tumor necrosis factor alpha gene with increased risk of preterm premature rupture of the fetal membranes. American Journal of Obstetrics and Gynecology 1999; 180:12971302.
  • 41
    Wilson AG, Di Giovine FS, Blakemore AIF, Duff GW. Single base polymorphism in the human tumour necrosis factor alpha (TNF α) gene detectable by Nco1 restriction of PCR product. Human Molecular Genetics 1992; 1:353.
  • 42
    Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proceedings of the National Academy of Sciences USA 1997; 94:31953199.
  • 43
    McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwjatkowski D. Variation in the TNF α promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371:508511.
  • 44
    Day CP, Grove J, Daly AK, Stewart MW, Avery PJ, Walker M. Tumour necrosis factor-alpha gene promoter polymorphism and decreased insulin resistance. Diabetologia 1998; 41:430434.DOI: 10.1007/s001250050926
  • 45
    Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, et al.The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. Journal of Clinical Investigation 1998; 102:13691376.
  • 46
    Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. European Journal of Immunogenetics 1997; 24:18.